Man sits looking at the horizon

Spravato Treatment Offers New Hope for Depression

Jul 16, 2020
Behavioral Health
Travco’s Director shares details about Spravato, which can provide relief from chronic depression when other treatments haven’t succeeded.

Chronic depression can be debilitating and devastating…especially when typical anti-depressant treatment doesn’t improves symptoms. That’s why Travco Behavioral Health is now offering Spravato—a nasal spray that is self-administered under medical supervision—for treatment-resistant depression.

Below, Cynthia O'Keefe, MSEd, LPCC-S, Director at Travco, answers some frequently asked questions about this treatment option.

What is Travco’s process for providing Spravato treatment?

  • Clients first participle in an initial psychiatric evaluation. For Spravato to be appropriate, they must meet requirements for treatment-resistant depression (symptoms have not improved despite two prior anti-depressant treatments).
  • A nurse then educates the client about Spravato’s side effects, reviews the client’s treatment plan and rules out any health conditions that would prevent the use of this medication (i.e. uncontrolled high blood pressure).
  • Next, Travco begins the prior authorization process with the client’s insurance company.
  • After approval is received, clients are provided with Spravato, which they self-administer under medical supervision at Travco Behavioral Health. Next, clients receive medical monitoring for two hours in relaxation rooms outfitted with recliners, TV’s, etc.
  • Following their appointment, clients are then driven home by either a support person or insurance-provided transportation.

How long does it take for the medication to work?

Improvements are generally noticed in four weeks, but some have noticed changes in less time.

Have your clients had success with this medication?

Yes, we have clients who have said Spravato has changed their lives. Also, we’ve found that family members typically notice improvements sooner than the clients themselves.

What is the typical length of Spravato treatment?

Spravato is a long-term medication, which is initially administered at two weekly medical appointments (for weeks one through four) and then once weekly (for weeks five through nine). After week nine, clients may choose to continue on the once weekly schedule or increase the duration between treatments to every other week.

Are there other requirements to take part in this treatment at Travco?

Yes, clients are required to participate in at least one counseling session per month (this can be with Travco or another provider). Also, Spravato is always prescribed in addition to an oral anti-depressant and all psychotropic mediation and services must be provided by Travco’s psychiatrist due to the intensity of Spravato.

 

If you or a loved one are interested in learning more about Spravato treatment at Travco, call us at 330.286.0050.

 

Man sits looking at the horizon

Spravato Treatment Offers New Hope for Depression

Jul 16, 2020
Behavioral Health
Travco’s Director shares details about Spravato, which can provide relief from chronic depression when other treatments haven’t succeeded.

Chronic depression can be debilitating and devastating…especially when typical anti-depressant treatment doesn’t improves symptoms. That’s why Travco Behavioral Health is now offering Spravato—a nasal spray that is self-administered under medical supervision—for treatment-resistant depression.

Below, Cynthia O'Keefe, MSEd, LPCC-S, Director at Travco, answers some frequently asked questions about this treatment option.

What is Travco’s process for providing Spravato treatment?

  • Clients first participle in an initial psychiatric evaluation. For Spravato to be appropriate, they must meet requirements for treatment-resistant depression (symptoms have not improved despite two prior anti-depressant treatments).
  • A nurse then educates the client about Spravato’s side effects, reviews the client’s treatment plan and rules out any health conditions that would prevent the use of this medication (i.e. uncontrolled high blood pressure).
  • Next, Travco begins the prior authorization process with the client’s insurance company.
  • After approval is received, clients are provided with Spravato, which they self-administer under medical supervision at Travco Behavioral Health. Next, clients receive medical monitoring for two hours in relaxation rooms outfitted with recliners, TV’s, etc.
  • Following their appointment, clients are then driven home by either a support person or insurance-provided transportation.

How long does it take for the medication to work?

Improvements are generally noticed in four weeks, but some have noticed changes in less time.

Have your clients had success with this medication?

Yes, we have clients who have said Spravato has changed their lives. Also, we’ve found that family members typically notice improvements sooner than the clients themselves.

What is the typical length of Spravato treatment?

Spravato is a long-term medication, which is initially administered at two weekly medical appointments (for weeks one through four) and then once weekly (for weeks five through nine). After week nine, clients may choose to continue on the once weekly schedule or increase the duration between treatments to every other week.

Are there other requirements to take part in this treatment at Travco?

Yes, clients are required to participate in at least one counseling session per month (this can be with Travco or another provider). Also, Spravato is always prescribed in addition to an oral anti-depressant and all psychotropic mediation and services must be provided by Travco’s psychiatrist due to the intensity of Spravato.

 

If you or a loved one are interested in learning more about Spravato treatment at Travco, call us at 330.286.0050.

 

Additional Wisdom & Stories

Additional Wisdom & Stories

Close X
Download any and all of the We Care More "Stop the Stigma" series ebooks and infographics.
Thank you!
Oops! Something went wrong while submitting the form. Please try again. If the issue continues, please contact us.